Docetaxel news

All news on Docetaxel (also known as Taxotere): plants, production capacities, investments and involved companies.

26 February 2026

Johnson & Johnson Reports Positive Early Results for Pasritamig and Docetaxel in Prostate Cancer

Phase 1b study shows pasritamig and docetaxel combo is safe and effective in prostate cancer, with high PSA response rates, supporting Phase 3 trials.

Who will be producing Docetaxel in the future?

Find out with chemXplore Alpha

Learn more